Continual learning in medical devices: FDA's action plan and beyond

Affiliations

¹ Institute of Law, University of Zurich, Ramistrasse 74, 8001 Zurich, Switzerland; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. Electronic address: kerstinnoelle.vokinger@usz.ch.
² ETH AI Center, ETH Zurich, Zurich, Switzerland.
³ Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Free article

Kerstin N Vokinger et al. Lancet Digit Health. 2021 Jun.

Free article

. 2021 Jun;3(6):e337-e338.

doi: 10.1016/S2589-7500(21)00076-5. Epub 2021 Apr 28.

¹ Institute of Law, University of Zurich, Ramistrasse 74, 8001 Zurich, Switzerland; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. Electronic address: kerstinnoelle.vokinger@usz.ch.
² ETH AI Center, ETH Zurich, Zurich, Switzerland.
³ Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

No abstract available

MeSH terms